BMS-986258
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-986258, covering 2025-09-18 to 2025-09-18. Get the full timeline:
Most recent: Clinical Trial Update: An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread [Phase 1, Phase 2]